Evidence map›Paper›PMID 36129434›Full record

ArticleThe Journal of cell biology2022

A specialized tyrosine-based endocytosis signal in MR1 controls antigen presentation to MAIT cells.

Hui Jing Lim, Jacinta M Wubben, Cristian Pinero Garcia, Sebastian Cruz-Gomez, Jieru Deng, Jeffrey Y W Mak, Abderrahman Hachani, Regan J Anderson, Gavin F Painter, Jesse Goyette and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Sorting endosomes play key roles in presentation ofbioRxiv : the preprint server for biology · 2025
    Article
  9. A cytoplasmic motif in HLA-E that drives clathrin-mediated endocytosis and VCP-associated postendocytic trafficking.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Hui Jing LimDepartment of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
Jacinta M WubbenInfection and Immunity Program and The Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, Clayton, Victoria, Australia.
Cristian Pinero GarciaEMBL Australia Node in Single Molecule Science, School of Medical Sciences, The University of New South Wales, Sydney, Australia.
Sebastian Cruz-GomezDepartment of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0001-8853-2295
Jieru DengDepartment of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0002-7786-4961
Jeffrey Y W MakInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-8011-4539
Abderrahman HachaniDepartment of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0001-8032-2154
Regan J AndersonFerrier Research Institute, Victoria University of Wellington, Wellington, New Zealand.ORCID 0000-0003-3467-9202
Gavin F PainterFerrier Research Institute, Victoria University of Wellington, Wellington, New Zealand.ORCID 0000-0002-1310-7769
Jesse GoyetteEMBL Australia Node in Single Molecule Science, School of Medical Sciences, The University of New South Wales, Sydney, Australia.ORCID 0000-0002-1008-1890
Shanika L AmarasingheEpigenetics and Development Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID 0000-0002-2229-8106
Matthew E RitchieEpigenetics and Development Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID 0000-0002-7383-0609
Antoine RoquillyDepartment of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0002-1029-6242
David P FairlieInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-7856-8566
Katharina GausEMBL Australia Node in Single Molecule Science, School of Medical Sciences, The University of New South Wales, Sydney, Australia.
Jamie RossjohnInfection and Immunity Program and The Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, Clayton, Victoria, Australia.ORCID 0000-0002-2020-7522
Jose A Villadangos *Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0001-6771-8891
Hamish E G McWilliam *Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0003-3479-3419
The University of Melbourne · AUUNSW Sydney · AUAustralian Regenerative Medicine Institute · AUThe University of Queensland · AUVictoria University of Wellington · NZInserm · FR

Funding

Investigating the basis of MAIT cell antigen potencyR01AI148407 · NIAID · UNIVERSITY OF MELBOURNE · PI MCCLUSKEY, JAMES · 2020 to 2024
$2.7M
ARC Centre of Excellence in Advanced Molecular Imaging CE140100011NIAID NIH HHS R01 AI148407NIH HHS R01AI148407
6 · The paper itself

Abstract

MR1 is a highly conserved microbial immune-detection system in mammals. It captures vitamin B-related metabolite antigens from diverse microbes and presents them at the cell surface to stimulate MR1-restricted lymphocytes including mucosal-associated invariant T (MAIT) cells. MR1 presentation and MAIT cell recognition mediate homeostasis through host defense and tissue repair. The cellular mechanisms regulating MR1 cell surface expression are critical to its function and MAIT cell recognition, yet they are poorly defined. Here, we report that human MR1 is equipped with a tyrosine-based motif in its cytoplasmic domain that mediates low affinity binding with the endocytic adaptor protein 2 (AP2) complex. This interaction controls the kinetics of MR1 internalization from the cell surface and minimizes recycling. We propose MR1 uses AP2 endocytosis to define the duration of antigen presentation to MAIT cells and the detection of a microbial metabolic signature by the immune system.

Indexed as

Antigen PresentationEndocytosisHistocompatibility Antigens Class IMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsAdaptor Protein Complex 2HumansLymphocyte ActivationTyrosineVitaminsAdaptor Protein Complex 2Histocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanTyrosineVitamins

Identifiers

PMID36129434
PMCPMC9499830
OpenAlexW4296700192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.